Estimated median progression free survival (PFS) in third-line treatment (180 mg dose) was 5.6 months. The comparable PFS threshold in standard of care treatments is 2.5 months 1.

Objectives To evaluate the association between tackle characteristics and suspected concussion among Canadian high school ...

Phosphatidylethanol reveals substantial underestimation of alcohol intake, especially in those with a history of excessive alcohol consumption. Incorporating phosphatidylethanol into diagnostic ...

The study investigated how the Board Independence affects the educational performance of Catholic-founded Grant-Aided ...